This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
On Thursday, the California Department of Food and Agriculture announced it is investigating the possible introduction of H5N1 bird flu in cattle at three dairy farms in the Central Valley. If confirmed, they would be the first known cases in that state. In a statement, officials said testing of samples from the three farms is currently underway in the state’s veterinary diagnostic lab.
Hims & Hers, one of the largest publicly traded telehealth companies in the country, has supercharged its business in the last several months by offering compounded versions of the patented weight loss drugs known as GLP-1s. It’s staking its future on the drugs, with plans to continue selling compounded GLP-1s even when shortages of the versions approved by regulators come to an end — a strategy that policy experts say could land the company in court.
Far fewer venture funding rounds were closed by cell and gene therapy developers over the first six months of 2024 than in prior years. Experts say there are several factors.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Concerns over health care’s carbon footprint typically revolve around issues like overly-air-conditioned hospitals and single-use medical supply waste. But researchers like Stanford University’s Jyothi Tirumalasetty think that asthma inhalers are also a good place to start when it comes to reducing emissions. Metered-dose inhalers, the most common type used to treat asthma or chronic obstructive pulmonary disease (COPD), use a propellant gas to aerosolize medications, which p
Medicines shortages and unavailability of community pharmacy staff are affecting adult social care providers in the UK, a survey by the Care Quality Commission (CQC) and Ipsos has suggested. Some 49% of adult social care providers responding to the survey said the medication support they receive from community pharmacies fully meets their needs and 39% […] The post Pharmacy pressures impacting care homes, suggests CQC survey appeared first on The Pharmacist.
Medicines shortages and unavailability of community pharmacy staff are affecting adult social care providers in the UK, a survey by the Care Quality Commission (CQC) and Ipsos has suggested. Some 49% of adult social care providers responding to the survey said the medication support they receive from community pharmacies fully meets their needs and 39% […] The post Pharmacy pressures impacting care homes, suggests CQC survey appeared first on The Pharmacist.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. We await one of the year’s biggest biotech readouts, and have lots of GLP-1 news today: Eli Lilly’s offer to slash pricing for Zepbound isn’t as magnanimous as it appears, and more.
Some pharmacies will soon be able to issue NHS electronic prescriptions as the next stage of the community pharmacy prescribing pathfinder project is rolled out. In a letter sent to regional pharmacy leads today, NHS England said it had procured a national clinical system to allow community pharmacists to generate prescriptions via the NHS Electronic Prescription […] The post BREAKING: Some pharmacies to start issuing NHS electronic prescriptions appeared first on The Pharmacist.
I dreamed of having children from a young age — so much so that I assumed I had to be a cisgender woman. Society had taught me that only a cisgender woman would want so badly to carry and birth a child, so I suppressed any feelings that suggested I might not be a cisgender woman. I did not realize I was transgender until well after I had my children.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Labor Day is almost here, which means the sprint to the end of 2024 is upon us. If you’re reading this late-August newsletter from the beach, the pool, or the mountains, I thank you for it.
The trial setbacks for Merck’s best-selling drug, which faces patent expiration in 2028, are a blow to the company’s plans for further indication expansion.
What’s behind the “great abandonment” in gene therapy R&D? How does a startup spend $213 million? And is Adam an optimist? We talk about all that and more on this week’s episode of “The Readout LOUD.” STAT biotech reporter Jonathan Wosen joins us to discuss gene therapy pioneer Jim Wilson’s exit from his decades-long tenure at the University of Pennsylvania.
Digital health firm Curio raises $10m+ in first-round financing that will be used to fund the rollout of its MamaLift Plus app for postpartum depression
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your inbox. Good morning and happy Thursday! Yesterday it was announced that my colleague Usha Lee McFarling won the 2024 Victor Cohn Prize for Excellence in Medical Science Reporting. I’m genuinely so honored to work in the same newsroom as Usha. Her stories — read them all — have elucidated so many under-covered, unresolved racial health inequities within in our health care syst
Shares in Neurocrine Biosciences took a tumble after it reported mid-stage data for a key pipeline drug for schizophrenia that failed to impress investors
Torrent Pharmaceuticals has announced that the U.S. FDA has issued an Establishment Inspection Report (EIR) for its manufacturing facility at Indrad, Gujarat. The inspection, conducted from June 3 to June 12, 2024, has been classified as Voluntary Action Indicated (VAI). The inspection process is now officially closed. The post U.S. FDA issues EIR with VAI classification for Torrent Pharmaceuticals’ Indrad facility appeared first on Express Pharma.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Ensuring that a generic drug meets FDA standards is crucial for maintaining the high quality and efficacy of medications. The FDA’s Office of Generic Drugs (OGD) plays a vital role in this process by following a rigorous review process to ensure that generic medications meet the same standards as their brand-name counterparts. The FDA’s review process for generic drugs involves several key steps.
Library staff across England will help people access online health services, as part of a new NHS England (NHSE) scheme to increase the use of the NHS App. The commissioner said that work is already underway in a number of libraries across England to support people to get started with the NHS App, and that […] The post Libraries to help patients use NHS app appeared first on The Pharmacist.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Testimony from the heads of Express Scripts, Optum Rx and Caremark in July defending pharmacy benefit managers’ business practices could be coming back to bite them.
Learn about drug repositioning, a strategy that involves finding new uses for existing drugs. Discover how this approach brings forgotten assets from shelves to patients and contributes to drug development.
Pfizer Inc. (NYSE: PFE) introduced PfizerForAll , a user-friendly digital platform designed to make access to healthcare and managing health and wellness more seamless for people across the U.S. The new, end-to-end experience will support the millions of Americans affected annually by common illnesses like migraine, COVID-19 or flu, and those seeking to protect themselves with adult vaccinations.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
364 
Let's personalize your content